Clinical Trials Logo

Filter by:
NCT ID: NCT05324098 Completed - Prostate Cancer Clinical Trials

Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy

Start date: March 8, 2022
Phase: N/A
Study type: Interventional

This clinical trial studies a digital platform, the supportive therapy in androgen deprivation (STAND-T), in achieving equity for men undergoing treatment with androgen deprivation therapy for prostate cancer. STAND-T is a digital platform that provides prostate health information, evidence-based materials and resources. STAND-T may help improve health, address symptoms, and promote equity in men with prostate cancer.

NCT ID: NCT05324007 Completed - Infant Behavior Clinical Trials

Babies' Expectations About Racial Interactions

BEARI
Start date: September 1, 2021
Phase: N/A
Study type: Interventional

This study will examine whether infants view race as an inductively useful social cue to predict third-party social relationships.

NCT ID: NCT05323747 Completed - Prostate Cancer Clinical Trials

Prospective Evaluation of a Commercially Available Hydrogel Spacer

BP-008
Start date: November 20, 2020
Phase:
Study type: Observational

Dosimetry efficacy evaluation of the hydrogel spacer

NCT ID: NCT05323708 Completed - Healthy Volunteers Clinical Trials

Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Bmab 1000 and Prolia® in Normal Healthy Volunteers: DENARIUS: DENosumab Pharmacokinetic equivAlence tRIal in Healthy volUnteerS

DENARIUS
Start date: March 9, 2022
Phase: Phase 1
Study type: Interventional

This study is to compare the Pharmacokinetics, Pharmacodynamics, safety, and tolerability of Bmab 1000 and Prolia® in normal healthy volunteers.

NCT ID: NCT05323630 Completed - Labium; Hypertrophy Clinical Trials

Evaluation of the Use of the Renuvion APR System in the Labia

Start date: April 19, 2023
Phase: N/A
Study type: Interventional

Labiaplasty is a procedure aimed at reducing lax or loose skin in the labia majora and/or minora due to childbirth, trauma, aging, genetics, or congenital disease.

NCT ID: NCT05323084 Completed - Quality of Life Clinical Trials

Effect of a Dietary Supplement on Quality of Life

SleepLift
Start date: January 4, 2022
Phase: N/A
Study type: Interventional

The purpose of this research study is to evaluate the effect of a combination of 3 food components to improve the quality of life in people who have trouble sleeping. Ten subjects with insomnia will drink 2 ounces of the supplement or a placebo for 1 week and after a 2 weeks washout period, will take the treatment they did not take the first week. Questionnaires to evaluate quality of life, a finger oximeter and a sleep study will be done before and after each treatment week.

NCT ID: NCT05322707 Completed - Asthma Clinical Trials

BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient

Start date: April 15, 2022
Phase: Phase 3
Study type: Interventional

The purpose of the study is to demonstrate the Pharmacodynamic bioequivalence of the test product to the reference product in adult patient with Asthma

NCT ID: NCT05322473 Completed - Clinical trials for Hidradenitis Suppurativa

Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa

Start date: April 25, 2022
Phase: Phase 2
Study type: Interventional

This is a study to demonstrate the clinical efficacy and safety of the nanobody® sonelokimab administered subcutaneously (sc) compared with placebo in the treatment of adult participants with moderate to severe hidradenitis suppurativa.

NCT ID: NCT05322382 Completed - SpO2 Clinical Trials

Accuracy of Pulse Oximeters With Profound Hypoxia

Start date: June 2, 2021
Phase: N/A
Study type: Interventional

This project aims to test the accuracy of pulse oximeters during mild, moderate, and severe hypoxia, i.e., a range of arterial HbO2 saturation from 100 down to 70%. A typical study will include at least ten subjects (at least 200 necessary data points to meet the ISO 80601-2-61:2017).

NCT ID: NCT05322317 Completed - Dementia Clinical Trials

Advance Care Planning (ACP) in Primary Care for Dementia

ADVANCE-PC
Start date: April 21, 2022
Phase: N/A
Study type: Interventional

ADVANCE-PC: Aligning Dementia & adVANce Care planning Education in Primary Care, is a communications and implementation support intervention that builds on existing ACP programs, understanding of dementia, and clinical expertise to provide training and technical assistance tailored to the needs of primary care clinicians and clinics that are often over-burdened and under-resourced. For this pilot, we will recruit six primary care clinics to test the ADVANCE-PC delivered using remote technology (ECHO). The pilot will include conducting one ECHO cycle and assessing the feasibility and acceptability of the program content and this mode of delivery (Aim 1) and testing pragmatic outcome assessment for the intervention (Aim 2).